Marcus Söderström

Marcus is a medicinal chemist and a licensed pharmacist. His work primarily focuses on the development of synthetic methods for drug discovery and the study of molecular interactions. Adressing the unmet need to treat Alzheimer’s disease and finding new targeted modalities for cancer medicine are examples of  his current work. At Uppsala University Marcus is a reseacher and postdoc at the Department of Medicinal Chemistry. Since 2024 he also holds the position of Beijer Researcher at the Beijer Laboratory for Pharmaceutical Research. 

Marcus is the primary liason between the Galvant Institute and Uppsala University and he is a key contributor to the TrebC project.